Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CUE
#3645
Cue Biopharma, Inc.
0.2
8
0.00%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-26.32%
6 month change
-65.85%
Year Change
-76.47%
Previous Close
0.2
8
Open
0.2
8
Bid
Ask
Low
0.2
8
High
0.2
8
Volume
6
Markets
US Stock Market
Healthcare
CUE
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
30.46 M
33.01 M
43.17 M
48.64 M
61.82 M
—
Valuation ratios
Enterprise value
306.15 M
308.98 M
71.32 M
90.95 M
44.96 M
170.83 M
Price to earnings ratio
—
—
-1.79
-2.5
-1.51
-5.9
Price to sales ratio
—
—
178.44
18.89
6.09
24.43
Price to cash flow ratio
—
—
-2.27
-3.18
-1.69
-6.49
Price to book ratio
—
—
1.44
3.43
3.51
5.82
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.45
-0.53
-0.58
0.82
1.26
1.29
Return on equity %
-0.57
-0.67
-0.81
1.37
2.32
3.43
Return on invested capital %
-849.98
-804.24
-1 067.99
—
952.32
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-1 427.96
-292.56
-10.02 K
774.3
411.58
3 427.21
EBITDA margin %
—
—
—
—
—
—
Net margin %
-1 419.79
-295.56
-9 975.38
753.27
403.39
3 399.86
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.36
5.35
6.68
3.01
1.84
6.13
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.16
0.01
0.09
0.22
0.22
Solvency ratios
Debt to assets ratio
—
—
0.09
0.07
0
0.02
Debt to equity ratio
—
—
0.12
0.11
0
0.03
Long term debt to total assets ratio
—
—
0.09
0.07
0
0
Long term debt to total equity ratio
—
—
0.12
0.11
0
0
Per share metrics
Operating cash flow per share
—
—
-1.17
0.87
0.64
0.4
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
0.23
0.09
0
0.01
Cash per share
—
—
2.14
1.06
0.4
1.05
Net current asset value per share
—
—
2.17
1.12
0.45
1.24
Tangible book value per share
—
—
1.84
0.81
0.31
0.72
Working capital per share
—
—
1.84
0.75
0.2
0.43
Book value per share
—
—
1.84
0.81
0.31
0.72
News
Cue Biopharma prices $10 million public offering at $0.28 per share
Cue Biopharma stock tumbles on public offering announcement
Cue Biopharma launches public offering of common stock and warrants
Cue Biopharma stock rating reiterated at Market Outperform by Citizens
ImmunoScape licenses Cue Biopharma technology for novel cancer therapy
Cue Biopharma earnings beat by $0.02, revenue fell short of estimates
Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates
CervoMed Inc. (CRVO) Reports Q3 Loss, Misses Revenue Estimates
Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates
Cue Biopharma and ImmunoScape partner on novel cancer therapy
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Beats Revenue Estimates
Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates